BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36383331)

  • 1. Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma.
    Alaimo L; Moazzam Z; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1392-1403. PubMed ID: 36383331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
    Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
    Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.
    Moazzam Z; Alaimo L; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Cloyd J; Ejaz A; Pawlik TM
    J Am Coll Surg; 2023 Apr; 236(4):804-813. PubMed ID: 36728327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis.
    Tsilimigras DI; Hyer JM; Paredes AZ; Diaz A; Moris D; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Dec; 27(13):5224-5232. PubMed ID: 32495285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.
    Alaimo L; Moazzam Z; Brown ZJ; Endo Y; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1340-1349. PubMed ID: 36029379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.
    Chen Q; Yang LX; Li XD; Yin D; Shi SM; Chen EB; Yu L; Zhou ZJ; Zhou SL; Shi YH; Fan J; Zhou J; Dai Z
    Tumour Biol; 2015 Jul; 36(7):5283-9. PubMed ID: 25672606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.
    Spolverato G; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Clark Gamblin T; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Tran TB; Wallis Marsh J; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):235-43. PubMed ID: 26059651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.
    Fu J; Zheng L; Tang S; Lin K; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Wang K; Li H; Zeng Y
    BMC Cancer; 2024 Mar; 24(1):358. PubMed ID: 38509498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Application of Artificial Intelligence to Investigate Long-Term Outcomes and Assess Optimal Margin Width in Hepatectomy for Intrahepatic Cholangiocarcinoma.
    Alaimo L; Moazzam Z; Endo Y; Lima HA; Butey SP; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Kitago M; Kim A; Ejaz A; Beane J; Cloyd J; Pawlik TM
    Ann Surg Oncol; 2023 Jul; 30(7):4292-4301. PubMed ID: 36952150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
    Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
    J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery.
    Kojima T; Umeda Y; Fuji T; Niguma T; Sato D; Endo Y; Sui K; Inagaki M; Oishi M; Ota T; Hioki K; Matsuda T; Aoki H; Hirai R; Kimura M; Yagi T; Fujiwara T
    PLoS One; 2020; 15(9):e0238392. PubMed ID: 32881910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study.
    Li H; Liu R; Qiu H; Huang Y; Liu W; Li J; Wu H; Wang G; Li D
    Front Oncol; 2022; 12():829407. PubMed ID: 35330712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
    Hu LS; Zhang XF; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Ann Surg Oncol; 2019 Aug; 26(8):2549-2557. PubMed ID: 31020501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
    Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma.
    Endo Y; Moazzam Z; Woldesenbet S; Araujo Lima H; Alaimo L; Munir MM; Shaikh CF; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    World J Surg; 2023 Jul; 47(7):1792-1800. PubMed ID: 37010541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.
    Merath K; Mehta R; Hyer JM; Bagante F; Sahara K; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Ejaz A; Pawlik TM
    Eur J Surg Oncol; 2019 Jun; 45(6):1084-1091. PubMed ID: 30871884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.
    Huang G; Zhang H; Yang Z; Li Q; Yuan H; Chen P; Xie C; Meng B; Zhang X; Chen K; Yu H
    World J Surg Oncol; 2024 Jan; 22(1):17. PubMed ID: 38200585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting overall and recurrence-free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi-institutional analysis.
    Shaikh CF; Alaimo L; Moazzam Z; Endo Y; Lima HA; Dawood Z; Munir MM; Pawlik TM
    J Surg Oncol; 2023 Jan; 127(1):73-80. PubMed ID: 36106350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.